Collegium Pharmaceutical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Collegium Pharmaceutical, Inc. (COLL) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $17.00 per share as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2021-02-25
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $17.00.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $15.05.
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $14.61.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $14.45.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2020-12-31 | $17.00 10-K · filed 2021-02-25 |
| 2019-12-31 | $15.05 10-K · filed 2020-02-27 |
| 2019-09-30 | $14.61 10-Q · filed 2019-11-06 |
| 2019-06-30 | $14.45 10-Q · filed 2019-08-07 |
| 2019-03-31 | $13.93 10-Q · filed 2019-05-08 |
| 2018-12-31 | $12.63 10-K · filed 2019-02-27 |
| 2018-09-30 | $12.71 10-Q · filed 2018-11-08 |
| 2018-06-30 | $12.73 10-Q · filed 2018-08-08 |
| 2018-03-31 | $13.17 10-Q · filed 2018-05-09 |
| 2017-12-31 | $12.86 10-K · filed 2018-03-07 |
| 2017-09-30 | $12.80 10-Q · filed 2017-11-08 |
| 2017-06-30 | $12.78 10-Q · filed 2017-08-09 |
| 2017-03-31 | $10.99 10-Q · filed 2017-05-10 |
| 2016-09-30 | $8.93 10-Q · filed 2016-11-10 |
| 2016-06-30 | $7.54 10-Q · filed 2016-08-11 |
| 2016-03-31 | $4.55 10-Q · filed 2016-05-11 |
| 2015-09-30 | $2.65 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |